Plasma cell CD20 expression

Primary aberrant expression or receptor up-regulation

Bushra Ajaz, Adnan Akhtar, Chung Che Chang, Melhem Solh, Kay Tangonan, Yasser Khaled

Research output: Contribution to journalLetter

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)444-446
Number of pages3
JournalLeukemia and Lymphoma
Volume55
Issue number2
DOIs
StatePublished - Jan 1 2014

Fingerprint

Antineoplastic Combined Chemotherapy Protocols
CD20 Antigens
Plasma Cells
Multiple Myeloma
Up-Regulation
Immunohistochemistry

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Plasma cell CD20 expression : Primary aberrant expression or receptor up-regulation. / Ajaz, Bushra; Akhtar, Adnan; Chang, Chung Che; Solh, Melhem; Tangonan, Kay; Khaled, Yasser.

In: Leukemia and Lymphoma, Vol. 55, No. 2, 01.01.2014, p. 444-446.

Research output: Contribution to journalLetter

Ajaz, Bushra ; Akhtar, Adnan ; Chang, Chung Che ; Solh, Melhem ; Tangonan, Kay ; Khaled, Yasser. / Plasma cell CD20 expression : Primary aberrant expression or receptor up-regulation. In: Leukemia and Lymphoma. 2014 ; Vol. 55, No. 2. pp. 444-446.
@article{371094201ef04be0bf5c4aaabf9ec603,
title = "Plasma cell CD20 expression: Primary aberrant expression or receptor up-regulation",
author = "Bushra Ajaz and Adnan Akhtar and Chang, {Chung Che} and Melhem Solh and Kay Tangonan and Yasser Khaled",
year = "2014",
month = "1",
day = "1",
doi = "10.3109/10428194.2013.802782",
language = "English (US)",
volume = "55",
pages = "444--446",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Plasma cell CD20 expression

T2 - Primary aberrant expression or receptor up-regulation

AU - Ajaz, Bushra

AU - Akhtar, Adnan

AU - Chang, Chung Che

AU - Solh, Melhem

AU - Tangonan, Kay

AU - Khaled, Yasser

PY - 2014/1/1

Y1 - 2014/1/1

UR - http://www.scopus.com/inward/record.url?scp=84904319906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904319906&partnerID=8YFLogxK

U2 - 10.3109/10428194.2013.802782

DO - 10.3109/10428194.2013.802782

M3 - Letter

VL - 55

SP - 444

EP - 446

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 2

ER -